What does Thalys Medical Technology Group Inc. do?

Thalys Medical Technology Group Inc. (603716.SS) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 603716.SS's market cap?

Thalys Medical Technology Group Inc. (603716.SS) has a market capitalization of approximately $3.64 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 603716.SS pay a dividend?

Yes — Thalys Medical Technology Group Inc. (603716.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 603716.SS profitable?

Thalys Medical Technology Group Inc. (603716.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

603716.SS

Thalys Medical Technology Group Inc.

SHH·Medical, Diagnostics & Research · Healthcare

¥16.13¥0.20+1.26%

Market cap¥3.64B·Market closed·Aug 27 3:10 AM UTC

Price Chart

¥16.13+¥0.20 (+1.26%)today

+39.72%CAGR +6.92%

Select date range

FromTo

Oct 31, 2016Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.080

Ex-Dividend DateJun 18

Payment DateJun 18

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateMay 20

Last Report DateSep 29

Reported vs Estimate−¥0.15

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥971.32M

Net Income−¥210.48M

Net Margin−21.7%

Operating Cash Flow−¥1.52M

Capital Expenditures¥5.13M

Free Cash Flow−¥6.65M

Return on Equity−20.5%

Return on Invested Capital−1.1%

Net Debt¥239.37M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 603716.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 603716.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 603716.SS and 80,000+ other tickers.

About Thalys Medical Technology Group Inc.

Thalys Medical Technology Group Inc. is a Chinese enterprise that specializes in providing intensive medical business and operational services. The company, established in 2004, is headquartered in Wuhan, China. It previously operated under the name Thalys Medical Technology Inc. before officially adopting its current designation in September 2020.

CEO: Zheng Wang
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: SHH
Employees: 1,045
Website: www.thalys.net.cn

Peers

Peers Tab

000710.SZ

Berry Genomics Co.,Ltd

Cap

¥3.3B

300288.SZ

Longmaster Information & Technology Co., Ltd.

Cap

¥3.4B

300683.SZ

Wuhan Hiteck Biological Pharma Co.,Ltd

Cap

¥3.4B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 603716.SS

What does Thalys Medical Technology Group Inc. do?: Thalys Medical Technology Group Inc. (603716.SS) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 603716.SS's market cap?: Thalys Medical Technology Group Inc. (603716.SS) has a market capitalization of approximately $3.64 billion, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 603716.SS pay a dividend?: Yes — Thalys Medical Technology Group Inc. (603716.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 603716.SS profitable?: Thalys Medical Technology Group Inc. (603716.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.